MBS8 / MonTa Biosciences 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MBS8 / MonTa Biosciences
NCT04855435: Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Recruiting
1
69
Europe
MBS8(1V270)
MonTa Biosciences ApS, Allucent
Advanced Solid Tumor
04/24
04/24

Download Options